UPau D'Arco

Umxholo

• Akukho bungqina baneleyo bokulinganisa ukusebenza ...
• Amanyathelo okhuseleko kunye nezilumkiso:

IPau d'arco ngumthi okhula kwihlathi elinemvula laseAmazon nakwezinye iindawo ezishushu zaseMzantsi nakuMbindi Merika. I-Pau d'arco iinkuni zixinene kwaye ziyala ukubola. Igama "pau d'arco" sisiPhuthukezi "somthi wokugoba," igama elifanelekileyo eliqwalasele ukusetyenziswa komthi ngabantu bomthonyama boMzantsi Merika ekwenzeni izaphetha zokuzingela. Amaxolo neenkuni zisetyenziselwa ukwenza iyeza.

Abantu basebenzisa i-pau d'arco kwiimeko ezinjengosulelo, umhlaza, isifo seswekile, izilonda zesisu, kunye nezinye ezininzi, kodwa abukho ubungqina benzululwazi obuxhasa ezi zinto zisetyenziswayo. Ukusebenzisa i-pau d'arco nako kunokungakhuselekanga, ngakumbi kwiidosi eziphezulu.

Iimveliso zorhwebo eziqukethe i-pau d'arco ziyafumaneka ngephilisi, ithebhulethi, isicatshulwa, umgubo kunye neefom zeti. Kodwa ngamanye amaxesha kunzima ukwazi ukuba yeyiphi imveliso yepau d'arco. Olunye uphononongo lubonakalisile ukuba ezinye iimveliso zepau d'arco ezithengiswa eCanada, eBrazil nasePortugal azinazo izinto ezisebenzayo ngezixa ezichanekileyo.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe PAU D'ARCO zezi zilandelayo:

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

• Ukunqongophala kwegazi.
• Intlungu efana neArthritis.
• Isifo sombefu.
• Isinyi kunye nokudlala kweprostate.
• Amathumba.
• IBronchitis.
• Umhlaza.
• Okubandayo Okunye.
• Seswekile.
• Urhudo.
• Onokhwekhwe.
• Fibromyalgia.
• Umkhuhlane.
• Usulelo olungenagwele, ibhaktiriya, intsholongwane, okanye iiparasites.
• Iintshulube emathunjini.
• Iingxaki zesibindi.
• Unyango.
• Izifo ezosulela ngokwabelana ngesondo (ukuvuza ngaphantsi, negcushuwa).
• Iingxaki zesisu.
• Ezinye iimeko.

Ubungqina obungakumbi buyafuneka ukukala ukusebenza kwepau d'arco kwezi zinto zisetyenziswayo.

Uphando lwakwangoko lubonisa ukuba i-pau d'arco inokuthintela iiseli zomhlaza ekukhuleni. Inokunciphisa ukukhula kwethumba ngokuthintela ithumba ekukhuleni kwemithambo yegazi eyimfuneko. Nangona kunjalo, iidosi ezifunekayo ukubangela iziphumo ze-anticancer kubonakala ngathi zibangela iziphumo ezibi kakhulu ebantwini.

UPau d'arco unjalo OKUNGENZEKA UKHUSELEKILE xa kuthathwa ngomlomo. Kwiidosi eziphezulu, ipau d'arco inokubangela isicaphucaphu, ukugabha, urhudo, isiyezi, nokopha ngaphakathi. Ukhuseleko lwepau d'arco kwiidosi eziqhelekileyo alwaziwa.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: Ngexesha lokukhulelwa, pau d'arco ngu OKUNGENZEKA UKHUSELEKILE xa ithathwa ngomlomo kwixabiso eliqhelekileyo, kwaye NGOKUFANELEKILEYO ngeedosi ezinkulu. Ayonelanga eyaziwayo ngokhuseleko lokuyifaka esikhumbeni. Hlala kwicala elikhuselekileyo kwaye uphephe ukusebenzisa ukuba ukhulelwe.

Akukho lwazi lwaneleyo lunokufumaneka malunga nokhuseleko lokuthatha i-pau d'arco ukuba uncancisa. Hlala kwicala elikhuselekileyo kwaye uphephe ukusetyenziswa.

Ugqirha: UPau d'arco unokucothisa ukujiya kwegazi kwaye unokunyusa ithuba lokopha ngexesha nasemva kotyando. Yeka ukuyisebenzisa okungenani iiveki ezi-2 ngaphambi kotyando olucwangcisiweyo.

Iphakathi

Lumka ngale nhlanganisela.

Amayeza acothisa ukujiya kwegazi (iAnticoagulant / iziyobisi zeAntiplatelet)

UPau d'arco unokucothisa ukujiya kwegazi. Ukuthatha i-pau d'arco kunye namayeza nawo acothayo ukucola kunokunyusa amathuba okugruzuka nokopha.

Amanye amayeza acothisa ukucoca igazi aquka iasprini, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, abanye), ibuprofen (Advil, Motrin, abanye), naproxen (Anaprox, Naprosyn, abanye), dalteparin (Fragmin), enoxaparin (Lovenox) , heparin, warfarin (Coumadin), kunye nezinye.

Iherbs kunye nezongezo ezinokucothisa igazi

UPau d'arco unokucothisa ukujiya kwegazi. Ukuthatha i-pau d'arco kunye namanye amayeza okanye izongezo ezikucothayo ukucola kunokunyusa amathuba okugruzuka nokopha kwabanye abantu. Ezi zityalo zibandakanya i-alfalfa, i-angelica, i-clove, i-danshen, i-chestnut yehashe, i-clover ebomvu, i-turmeric kunye nezinye.

Akukho kunxibelelana kwaziwayo nokutya.

Idosi efanelekileyo yepau d'arco ixhomekeke kwizinto ezininzi ezinje ngeminyaka yomsebenzisi, impilo, kunye nezinye iimeko. Ngeli xesha akukho lwazi lwaneleyo lwesayensi ukumisela uluhlu olufanelekileyo lweedosi zepau d'arco. Gcina ukhumbula ukuba iimveliso zendalo azisoloko zikhuselekile kwaye iidosi zibalulekile. Qiniseka ukuba ulandela umkhombandlela ofanelekileyo kwiilebheli zemveliso kwaye uqhagamshelane nosokhemesti okanye ugqirha okanye olunye uqeqesho kwezempilo ngaphambi kokusebenzisa.

Ébénier de Guyane, Ébène Vert, Handroanthus impetiginosus, Ipe, Ipe Roxo, Ipes, Lapacho, Lapacho Colorado, Lapacho Morado, Lapacho Negro, Lébène, Pink Trumpet Tree, Purple Lapacho, Quebracho, Red Lapacho, Tabebuia avellanosae, Tabebuia avellanosae, , Tabebuia palmeri, Taheebo, Teeebo Tea, Tecoma impetiginosa, Thé Taheebo, Trumpet Bush.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.

1. Algranti E, Mendonça EM, Ali SA, Kokron CM, Raile V. Isifuba somsebenzi esibangelwa luthuli lwe-Ipe (Tabebuia spp). J Uphando lweAllergol kwiKlinikhi ye-Immunol 2005; 15: 81-3. Jonga i-abstract.
2. UZhang L, Hasegawa I, Ohta T.I-anti-inflammatory cyclopentene derivatives ezivela kwi-bark yangaphakathi yeTabebuia avellanedae. UFitoterapia 2016; 109: 217-23. Jonga i-abstract.
3. U-Lee S, uKim IS, u-Kwak TH, uYoo HH. Ukuthelekisa isifundo semetabolism se-ß-lapachone kwimouse, i-rat, inja, inkawu, kunye ne-microsomes yesibindi somntu kusetyenziswa ulwelo lwe-chromatography-tandem mass spectrometry. J Amayeza oBuchwephesha boTywala ngo-2013; 83: 286-92. Jonga i-abstract.
4. UHussain H, uKrohn K, uAhmad VU, et al. ILapachol: isishwankathelo. I-Arkivok 2007 (ii): 145-71.
5. IPereira IT, uBurci LM, da Silva LM, et al. Isiphumo se-antiulcer sokukhupha ixolo leTabebuia avellanedae: ukwenziwa kweseli kwandiswe kwisisu esiswini ngexesha lokuphilisa. UPhytother Res 2013; 27: 1067-73. Jonga i-abstract.
6. UMakedo L, uFernandes T, uSilveira L, et al. Umsebenzi we-ap-Lapachone kulungelelwaniso kunye ne-antimicrobials eqhelekileyo ngokuchasene ne-methicillin ukumelana ne-Staphylococcus aureus strains. I-Phytomedicine 2013; 21: 25-9. Jonga i-abstract.
7. IPires TC, iDias MI, uCalhelha RC, et al. Iipropathi ze-Bioactive zeTabebuia impetiginosa-based phytopreparations kunye ne-phytoformulations: uthelekiso phakathi kwezicatshulwa kunye nezongezo zokutya. Iimolekyuli 2015; 1; 20: 22863-71. Jonga i-abstract.
8. Jonga i-DVC. I-taheebo yorhwebo ayinaso isithako esisebenzayo. Ileta yoLwazi 726 Ngaba uFarm J. 1991; 121: 323-26.
9. UAwang DVC, uDawson BA, u-Ethier JC, et al. Iindawo zeNaphthoquinone zoRhwebo lweLapacho / Pau d'arco / Iimveliso zeTaheebo. J Herbs Spic Med Izityalo. Ngo-1995; 2: 27-43.
10. I-Nepomuceno JC. ILapachol kunye neziphumo zayo njengamayeza anokubakho kunyango lomhlaza. Ku: Izityalo kunye noLimo-iBiology kunye noPhando lweBiotechnology, 1st ed. IConcept Press Ltd .. Ibuyisiwe kwi: https://www.researchgate.net/profile/Julio_Nepomuceno/publication/268378689_Lapachol_and_its_derivatives_as_potential_drugs_for_cancer_treatment/links/5469c8640cf20dedafd103e1.pdf.
11. Iipayile JB, Morais VM, Lima CR. Resistência natural de nove madeiras do semi-árido brasileiro a fungos causadores da podridão-mole. R. vrvore, 2005; 29: 365-71.
12. UKreher B, uLotter H, uCordell GA, uWagner H. New Furanonaphthoquinones kunye namanye amaTyala eTabebuia avellanedae kunye neZenzo zabo zokuGqibela kwi-vitro. IPlanta Med. Ngo-1988; 54: 562-3. Jonga i-abstract.
13. de Almeida ER, da Silva Filho AA, dos Santos ER, Lopes CA. Isenzo sokuchasana ne-lapachol. J U-Ethnopharmacol. Ngo-1990; 29: 239-41. Jonga i-abstract.
14. UGuiraud P, uSteiman R, uCampos-Takaki GM, uSeigle-Murandi F, uSimeon de Buochberg M. Thelekisa imisebenzi yokulwa ne-antibacterial kunye ne-antifungal ye-lapachol kunye ne-beta-lapachone. IPlanta Med. Ngo-1994; 60: 373-4. Jonga i-abstract.
15. Vimba i-JB, i-Serpick AA, i-Miller W, i-Wiernik PH. Izifundo zokuqala zeklinikhi kunye ne-lapachol (NSC-11905). Umhlaza Chemother Rep 2. 1974; 4: 27-8. Jonga i-abstract.
16. UKung, H. N., Yang, M. J., Chang, C. F., Chau, Y. P., kunye noLu, K. S. In vitro nakwimisebenzi ye-vivo yokuphilisa inxeba yokukhuthaza unyango lwe-beta-lapachone. Ndingu. J Physiol Cell Physiol 2008; 295: C931-C943. Jonga i-abstract.
17. Byeon, S. E., Chung, J. Y., Lee, Y. G., Kim, B. H., Kim, K. H., no-Cho, J. Y. In vitro nakwi-vivo iziphumo ezichasene nokuvuvukala kwe-taheebo, ukukhutshwa kwamanzi kwi-bark yangaphakathi yeTabebuia avellanedae. J U-Ethnopharmacol. I-9-2-2008; 119: 145-152. Jonga i-abstract.
18. I-Twardowschy, A., Freitas, CS, Baggio, CH, Mayer, B., dos Santos, AC, Pizzolatti, MG, Zacarias, AA, dos Santos, EP, Otuki, MF, kunye neMarques, umsebenzi we-MC Antiulcerogenic wokukhupha ixolo. UTabebuia avellanedae, uLorentz ex Griseb. J U-Ethnopharmacol. 8-13-2008; 118: 455-459. Jonga i-abstract.
19. I-Queiroz, ML, Valadares, MC, Torello, CO, Ramos, AL, Oliveira, AB, Rocha, FD, Arruda, VA, kunye neAccorci, WR Izifundo zothelekiso lweziphumo zeTabebuia avellanedae bark extract kunye ne-beta-lapachone kwimpendulo ye-hematopoietic yeempuku ezithwala ithumba. J U-Ethnopharmacol. 5-8-2008; 117: 228-235. Jonga i-abstract.
20. I-Savage, RE, Tyler, AN, Miao, XS, kunye ne-Chan, TC Ukuchongwa kwenoveli glucosylsulfate conjugate njengemetabolite ye-3,4-dihydro-2,2-dimethyl-2H-naphtho [1,2-b] pyran- I-5,6-dione (ARQ 501, beta-lapachone) kwizilwanyana ezanyisayo. Ukuchithwa kweMetab yeziyobisi. Ngo-2008; 36: 753-758. Jonga i-abstract.
21. Yamashita, M., Kaneko, M., Iida, A., Tokuda, H., kunye noNishimura, K. Stereoselective synthesis kunye cytotoxicity yomhlaza chemopreventive naphthoquinone evela Tabebuia avellanedae. I-Bioorg, iMed Chem, kunye neLett. 12-1-2007; 17: 6417-6420. Jonga i-abstract.
22. UKim, S. O., Kwon, J. I., Jeong, YK, Kim, G. Y., Kim, N. D., kunye noChoi, YH H.Ukwenziwa kwe-Egr-1 kunxulunyaniswa namandla okulwa ne-metastatic kunye ne-anti-invasive ye-beta-lapachone kwiiseli ze-hepatocarcinoma zabantu. I-Biosci Biotechnol Biochem 2007; 71: 2169-2176. Jonga i-abstract.
23. de Cassia da Silveira E Sa kunye no-Oliveira, Guerra M. Ityhefu yokuzala yokuzala ye-lapachol kumadoda amadala eWistar amagundane angeniswe kunyango lwexesha elifutshane. Phytother.Res. Ngo-2007; 21: 658-662. Jonga i-abstract.
24. Kung, H.N, Chien, C., Chau, G., Y., Don, M., Lu, K. S., no Chau, Y. P. Ukubandakanywa kwe-NO / cGMP ukusayina kwi-apoptotic kunye ne-anti-angiogenic yeziphumo ze-beta-lapachone kwiiseli ze-endothelial kwi-vitro. Iselfowuni iPhysol 2007; 211: 522-532. Jonga i-abstract.
25. I-Woo, HJ, iPaki, KY, Rhu, CH, Lee, WH, Choi, BT, Kim, GY, Park, YM, kunye neChoi, YH Beta-lapachone, i-quinone ehlukaniswe neTabebuia avellanedae, inciphisa i-apoptosis kwi-HepG2 hepatoma cell line ngokungeniswa kweBax kunye nokusebenza kwecaspase. J Med Ukutya 2006; 9: 161-168. Jonga i-abstract.
26. Nyana, DJ, Lim, Y., Ipaki, YH, Chang, SK, Yun, YP, Hong, JT, Takeoka, GR, Lee, KG, Lee, SE, Kim, MR, Kim, JH, kunye nePaki, BS Inhibitory. Iziphumo ze-Tabebuia impetiginosa i-bark yangaphakathi ekhutshwe kwi-platelet aggregation kunye ne-vascular smooth cell cell proliferation ngokusebenzisa ukucinywa kwe-arachidonic acid inkululeko kunye ne-ERK1 / 2 MAPK activation. J U-Ethnopharmacol. 11-3-2006; 108: 148-151. Jonga i-abstract.
27. U-Lee, JI, Choi, DY, Chung, HS, Seo, HG, Woo, HJ, Choi, BT, kunye no-Choi, YH beta-lapachone induces ukukhula kokuthintela kunye ne-apoptosis kwiiseli zomhlaza wesinyi ngokumodareyitha kosapho lwe-Bcl-2 kunye nokusebenza kwenkqubo iikhasethi. Yazisa iOncol. Ngo-2006; 28: 30-35. Jonga i-abstract.
28. UPereira, EM, Machado, Tde B., Leal, IC, Jesus, DM, Damaso, CR, Pinto, AV, Giambiagi-deMarval, M., Kuster, RM, kunye neSantos, KR Tabebuia avellanedae naphthoquinones: umsebenzi ochasene nemethicillin-resistant staphylococcal strain, cytotoxic activity and in vivo dermal irritability analysis. UAnn. Clin. Microbiol. Izixhobo zokulwa. Ngo-2006; 5: 5. Jonga i-abstract.
29. UFelicio, A., Chang, C. V., Brandao, M. A., Peters, V. M., kunye noGuerra, Mde O. Ukukhula komntwana kwiigundane eziphathwe nge-lapachol. Ukuthintela ukukhulelwa 2002; 66: 289-293. Jonga i-abstract.
30. UGuerra, Mde O., Mazoni, A. S., Brandao, M. A., kunye noPeter, V. M. Toxicology yeLapachol kwiigundane: umbungu wesibeleko. UBraz. J Biol. 2001; 61: 171-174. Jonga i-abstract.
31. I-Lemos OA, iSanches JC, uSilva IE, et al. Iziphumo zeGenotoxic zeTabebuia impetiginosa (Mart. Ex DC.) Standl. (I-Lamiales, iBignoniaceae) ikhutshwe kwiigundane zaseWistar. Uhlobo lweMol Biol 2012; 35: 498-502. Jonga i-abstract.
32. I-Kiage-Mokua BN, Roos N, Schrezenmeir J.Lapacho Tea (Tabebuia impetiginosa) Ukukhupha kuthintela iPancreatic Lipase kunye nokuCothisa ukuPhuma kweTriglyceride kwiRats. I-Phytother Res 2012 ngo-Mar 17. ikhonkco: 10.1002 / ptr.4659. Jonga i-abstract.
33. de Melo JG, Santos AG, de Amorim EL, okqhubekayo. Izityalo zonyango ezisetyenziswa njengee-antitumor agents eBrazil: indlela ye-ethnobotanical. Ubungqina bokuSebenza ngokuNcedisayo kwi-Alternat Med 2011; 2011: 365359. Epub 2011 Mar 8. Jonga into engaqondakaliyo.
34. UGómez Castellanos JR, Prieto JM, Heinrich M. Red Lapacho (Tabebuia impetiginosa) -into yorhwebo lwe-ethnopharmacological jikelele? J U-Ethnopharmacol 2009; 121: 1-13. Jonga i-abstract.
35. IPaki BS, uLee HK, uLee SE, et al. Umsebenzi we-Antibacterial weTabebuia impetiginosa Martius ex DC (Taheebo) ngokuchasene neHelicobacter pylori. J U-Ethnopharmacol 2006; 105: 255-62. Jonga i-abstract.
36. IPaki BS, uKim JR, uLee SE, et al. Ukukhetha ukukhula-kokuthintela iziphumo zeekhompawundi ezichongiweyo kwiTabebuia impetiginosa bark yangaphakathi kwiintsholongwane zomntu emathunjini. J Agric Ukutya Chem 2005; 53: 1152-7. Jonga i-abstract.
37. UKoyama J, Morita I, Tagahara K, Hirai K. Cyclopentene dialdehydes ovela eTabebuia impetiginosa. Unyango lwe-Phytochemistry 2000; 53: 869-72. Jonga i-abstract.
38. IPaki BS, uLee KG, uShibamoto T, et al. Umsebenzi we-Antioxidant kunye nokubonakaliswa kwezinto ezinobuzaza beTaheebo (Tabebuia impetiginosa Martius ex DC). J Agric Ukutya Chem 2003; 51: 295-300. Jonga i-abstract.

Ukuhlaziywa okokugqibela-08/16/2018